Cancer in the headlines, Feb 19

February 19, 2010 by  
Filed under CANCER

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

FDA Cancer Drug Approval Rate Highlighted in JNCI
A review in the Journal of the National Cancer Institute gives positive feedback on US FDA’s rate of cancer drug approval. Between July 2005 and end of 2007, the regulatory body Office of Oncology Drug Products approved more than 50 new indications in oncology as well as hematology drugs and biologics. In addition, the review reports:

FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
One of the latest approved cancer drug is Rituxan (rituximab), indicated for the treatment of chronic lymphocytic leukemia (CLL). CLL is a slowly progressing cancer of the blood and bone marrow primarily affecting people older than 50. It arises from a group of white blood cells known as B-cells—part of the body’s immune system. About 16,000 people in the US are diagnosed with CLL each year, resulting in 4,400 deaths. Rituxan is indicated for patients for chemotherapy-naive as well as chemotherapy-experienced patients not responding to ongoing therapy. Rituxan is administered in combination with two other chemotherapy drugs, fludarabine and cyclophosphamide.

According to Dr. Richard Pazdur, director of the Office of Oncology Drug Products in the FDA’s Center for Drug Evaluation and Research

“Rituxan is the third drug approved for the treatment of CLL since 2008 and underscores FDA’s commitment to expediting the development and approval of drugs for patients with serious and life-threatening diseases.”

Merck: Studies boost Gardasil for new uses
The HPV vaccine Gardasil is effective against other conditions, according to its manufacturer Merck. Gardasil was initially approved for prevention of cervical cancer in females from age 9 to 26. Last year, it was approved for the prevention of genital warts in males aged 9 to 26. New studies indicate that the vaccine is also effective in preventing cervical cancer and genital warts in older women (up to 45 years) and anal cancer in men. Merck is applying for approval for these new indications.

Wishing you all a relaxing weekend!

Related Posts with Thumbnails
Print Friendly, PDF & Email
  • Winsor Pilates

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!


Random Battling For Health Products From Our Store

NOTE: The contents in this blog are for informational purposes only, and should not be construed as medical advice, diagnosis, treatment or a substitute for professional care. Always seek the advice of your physician or other qualified health professional before making changes to any existing treatment or program. Some of the information presented in this blog may already be out of date.

Read previous post:
Statins and diabetes

Some antidiabetes drugs are said to increase risk for cardiovascular disease. Can it also be true the other way around?...